Literature DB >> 17684814

Community-associated infections in children--update on community-associated methicillin-resistant Staphylococcus aureus for the practitioner.

Lilly Cheng Immergluck1.   

Abstract

Nationally, the incidence of infections in children due to resistant Staphylococcus aureus originating from the community (CA-MRSA) is increasing at alarming rates. The predominant clinical syndrome caused by CA-MRSA in children is skin and soft tissue infections (SSTIs), and many of these children suffer from recurrence of these SSTIs. Most studies published in the medical literature have evaluated infection and colonization due to resistant staphylococcal bacteria among people with previously identified risk factors, eg, indwelling catheters, chronic illnesses. Established risk factors for MRSA infection include recent hospitalization or surgery, stay at long-term care facility, history of prolonged antibiotic use, and history of injection drug use. However, little is known about the risk factors associated with CA-MRSA in children. This paper will summarize the current epidemiology surrounding CA-MRSA, the associated clinical syndromes and most common presentations, and the latest strategies to not only treat but to prevent the recurrence of the infections caused by this resistant bacterium, which originated from the community.

Entities:  

Mesh:

Year:  2007        PMID: 17684814

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  2 in total

1.  Assessing Nursing Care Needs of Children With Complex Medical Conditions: The Nursing-Kids Intensity of Care Survey (N-KICS).

Authors:  Ann-Margaret Navarra; Rona Schlau; Meghan Murray; Linda Mosiello; Laura Schneider; Olivia Jackson; Bevin Cohen; Lisa Saiman; Elaine L Larson
Journal:  J Pediatr Nurs       Date:  2016-01-07       Impact factor: 2.145

Review 2.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.